Acorah Software Products - Accounts Production 16.7.461 false true 31 October 2024 1 November 2023 false 1 November 2024 31 October 2025 31 October 2025 12951166 Ms M Heaslop Dr J Davies Dr H Jopling Mr C Black iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12951166 2024-10-31 12951166 2025-10-31 12951166 2024-11-01 2025-10-31 12951166 frs-core:CurrentFinancialInstruments 2025-10-31 12951166 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-11-01 2025-10-31 12951166 frs-core:OtherResidualIntangibleAssets 2025-10-31 12951166 frs-core:OtherResidualIntangibleAssets 2024-11-01 2025-10-31 12951166 frs-core:OtherResidualIntangibleAssets 2024-10-31 12951166 frs-core:SharePremium 2025-10-31 12951166 frs-core:ShareCapital 2025-10-31 12951166 frs-core:RetainedEarningsAccumulatedLosses 2025-10-31 12951166 frs-bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 12951166 frs-bus:FilletedAccounts 2024-11-01 2025-10-31 12951166 frs-bus:SmallEntities 2024-11-01 2025-10-31 12951166 frs-bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 12951166 frs-bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 12951166 frs-bus:Director1 2024-11-01 2025-10-31 12951166 frs-bus:Director2 2024-11-01 2025-10-31 12951166 frs-bus:Director3 2024-11-01 2025-10-31 12951166 frs-bus:Director4 2024-11-01 2025-10-31 12951166 frs-countries:EnglandWales 2024-11-01 2025-10-31 12951166 2023-10-31 12951166 2024-10-31 12951166 2023-11-01 2024-10-31 12951166 frs-core:CurrentFinancialInstruments 2024-10-31 12951166 frs-core:SharePremium 2024-10-31 12951166 frs-core:ShareCapital 2024-10-31 12951166 frs-core:RetainedEarningsAccumulatedLosses 2024-10-31
Registered number: 12951166
Europa Life Sciences Limited
Unaudited Financial Statements
For The Year Ended 31 October 2025
Bromley Clackett Ltd
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3
Page 1
Balance Sheet
Registered number: 12951166
2025 2024
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 3,032 2,642
3,032 2,642
CURRENT ASSETS
Debtors 5 3,712 16,777
Cash at bank and in hand 176,340 1,311
180,052 18,088
Creditors: Amounts Falling Due Within One Year 6 (65,241 ) (74,116 )
NET CURRENT ASSETS (LIABILITIES) 114,811 (56,028 )
TOTAL ASSETS LESS CURRENT LIABILITIES 117,843 (53,386 )
NET ASSETS/(LIABILITIES) 117,843 (53,386 )
CAPITAL AND RESERVES
Called up share capital 7 5 2
Share premium account 299,997 -
Profit and Loss Account (182,159 ) (53,388 )
SHAREHOLDERS' FUNDS 117,843 (53,386)
Page 1
Page 2
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr J Davies
Director
8th January 2026
The notes on page 3 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Europa Life Sciences Limited is a private company, limited by shares, incorporated in England & Wales, registered number 12951166 . The registered office is 128 City Road, London, EC1V 2NX.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Intangible Fixed Assets and Amortisation - Other Intangible
Included within intangible assets is a patent. It is amortised to profit and loss account over its estimated economic life of 20 years.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
4. Intangible Assets
Patent
£
Cost
As at 1 November 2024 2,642
Additions 390
As at 31 October 2025 3,032
Net Book Value
As at 31 October 2025 3,032
As at 1 November 2024 2,642
5. Debtors
2025 2024
£ £
Due within one year
Other debtors 3,712 16,777
6. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Trade creditors 282 33,616
Other loans 47,050 40,500
Other creditors 10,893 -
Taxation and social security 7,016 -
65,241 74,116
7. Share Capital
2025 2024
£ £
Called Up Share Capital not Paid - 2
Called Up Share Capital has been paid up 5 -
Amount of Allotted, Called Up Share Capital 5 2
Page 3